BSN INVEST ApS, BROBY

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  1.0% 4.0% 1.0% 1.0% 1.7%  
Credit score (0-100)  88 50 85 85 71  
Credit rating  A BBB A A A  
Credit limit (kDKK)  161.5 0.0 56.7 57.4 1.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  -14.8 -21.0 -15.0 -13.0 -15.0  
EBITDA  -14.8 -21.0 -15.0 -13.0 -15.0  
EBIT  -14.8 -21.0 -15.0 -13.0 -15.0  
Pre-tax profit (PTP)  608.9 -1,991.0 270.0 174.0 80.2  
Net earnings  608.5 -1,994.0 262.0 242.0 74.2  
Pre-tax profit without non-rec. items  609 -1,991 270 174 80.2  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  2,808 814 1,077 1,204 1,160  
Interest-bearing liabilities  724 676 489 670 675  
Balance sheet total (assets)  3,538 1,498 1,790 1,880 1,842  

Net Debt  -73.1 -166 -576 -233 -294  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -14.8 -21.0 -15.0 -13.0 -15.0  
Gross profit growth  88.2% -41.8% 28.6% 13.3% -15.7%  
Employees  0 0 0 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  3,538 1,498 1,790 1,880 1,842  
Balance sheet change%  20.3% -57.7% 19.5% 5.0% -2.0%  
Added value  -14.8 -21.0 -15.0 -13.0 -15.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -4.0 -5.0 -5.0 -5.0 -5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  19.3% -78.3% 17.8% 19.5% 6.2%  
ROI %  19.4% -78.5% 19.2% 20.8% 6.2%  
ROE %  23.8% -110.1% 27.7% 21.2% 6.3%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  79.4% 54.3% 60.2% 64.0% 63.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  493.3% 790.5% 3,840.0% 1,792.3% 1,953.9%  
Gearing %  25.8% 83.0% 45.4% 55.6% 58.2%  
Net interest  0 0 0 0 0  
Financing costs %  2.6% 2.7% 3.9% 31.6% 5.1%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.1 1.3 1.5 1.4 1.5  
Current Ratio  1.1 1.3 1.5 1.4 1.5  
Cash and cash equivalent  796.9 842.0 1,065.0 903.0 968.9  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -722.9 -602.0 -698.0 -625.0 -643.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 -13 -15  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 -13 -15  
EBIT / employee  0 0 0 -13 -15  
Net earnings / employee  0 0 0 242 74